Melatonin and sleep are connected through a real, well-understood biological mechanism, melatonin is the hormone your pineal gland releases in response to darkness, signaling to your body that it’s time to wind down. Where it gets more complicated is exogenous, supplemental melatonin’s actual effectiveness as a general insomnia treatment. The American Academy of Sleep Medicine’s 2017 clinical practice guideline explicitly recommends against using melatonin as a treatment for sleep onset or sleep maintenance insomnia in adults, citing low-quality evidence and a clinically insignificant effect size, the studied 2 mg dose reduced sleep onset time by only about 9 minutes compared to placebo. Melatonin’s evidence is considerably stronger for a different purpose: correcting circadian rhythm misalignment, such as jet lag, shift work adjustment, and delayed sleep phase, and there’s more support for its use specifically in older adults, whose natural melatonin production has declined with age. This is educational information, not medical advice.
From the Practice
[RILEY: add a real observation here, for example how you explain to clients why melatonin didn’t work the way they expected, or how you help someone decide whether their sleep issue actually fits melatonin’s real use case.]
What Is Melatonin, and What Does It Actually Do?
Melatonin is a hormone produced by your pineal gland, released in response to darkness and suppressed by light exposure. Its core biological role is chronobiotic, meaning it helps regulate the timing of your sleep-wake cycle, rather than acting as a direct sedative the way many prescription sleep medications do. This distinction matters: melatonin is better understood as a signal that tells your body “it’s nighttime” than as something that forces you to sleep. This is why its evidence is strongest for correcting circadian timing problems rather than general difficulty sleeping.
Does Melatonin Actually Help With Insomnia?
This is where the popular narrative and the clinical guidelines diverge sharply. The American Academy of Sleep Medicine’s 2017 clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults reviewed the available evidence and issued a “weak” recommendation against using melatonin for either sleep onset or sleep maintenance insomnia. The reasoning: trials using a 2 mg dose found only about a 9-minute reduction in sleep onset latency compared to placebo, well below the threshold generally considered clinically meaningful, combined with low overall evidence quality due to publication bias, inconsistency between studies, and imprecise results.
This is a genuinely important finding to sit with, given how widely melatonin is used and recommended informally. The guideline isn’t saying melatonin is dangerous, it’s saying the evidence doesn’t support it as an effective treatment for general chronic insomnia in adults, which is a different (and more specific) claim than “melatonin doesn’t work at all.”
At a Glance: What Sleep Medicine Guidelines Actually Say About Melatonin
| Guideline / Body | Recommendation |
|---|---|
| American Academy of Sleep Medicine (2017), adults, general chronic insomnia | Recommends against use (weak recommendation, low-quality evidence) |
| British Association for Psychopharmacology | Prolonged-release melatonin recommended as first-line for insomnia in adults over 55 specifically |
| General circadian rhythm applications (jet lag, shift work, delayed sleep phase) | Stronger evidence base; melatonin’s core mechanism is well-suited to these specific uses |
| Regulatory status | Unregulated dietary supplement in the US; prescription-only medication in the UK and EU |
Then Why Is Melatonin So Popular?
A few things are likely happening at once. Melatonin has a strong safety profile relative to prescription sedatives, with generally mild side effects, which makes it an appealing lower-risk option even when its average effect size is modest. Some individuals may genuinely respond well to it, particularly if their sleep issue is more circadian (timing-related) than a general difficulty sleeping. And because melatonin is sold over the counter and marketed heavily, its popularity has grown well beyond what the general-insomnia evidence base actually supports, more a reflection of accessibility and marketing than of the guideline-level evidence for its use as a nightly sleep aid.
Where Melatonin’s Evidence Is Actually Strong
Melatonin’s mechanism, signaling circadian timing rather than directly sedating, makes it much better suited to problems where your internal clock is misaligned with when you need to sleep, rather than general insomnia. This includes jet lag, adjusting to shift work schedules, and delayed sleep phase syndrome, situations where the goal is shifting when your body wants to sleep, not simply making you sleepier. We go deeper on this specific use case in Melatonin for Jet Lag and Shift Work.
There’s also more support for melatonin specifically in older adults: melatonin production naturally declines with age, and some clinical guidelines outside the US, including a British Association for Psychopharmacology consensus statement, recommend prolonged-release melatonin as a first-line option for insomnia specifically in people over 55, a notably different conclusion than the general-adult recommendation.
A Regulatory Detail Worth Knowing
In the United States, melatonin is sold as an unregulated dietary supplement, meaning manufacturers aren’t required to prove effectiveness or verify label accuracy before selling it. In the United Kingdom and much of the European Union, by contrast, melatonin (such as the brand Circadin) is available only by prescription, regulated as a medication specifically for insomnia in adults over 55. This regulatory gap partly reflects the same evidence nuance discussed above, stronger support for a specific population and formulation, weaker support for general, unrestricted use.
If your sleep issue doesn’t seem to fit melatonin’s actual evidence-supported use case, book a consultation with The Sleep Consultant so we can help you figure out what will actually address the root cause.
Where to Go Next
This pillar is the hub for our Melatonin & Sleep Aids series. A few places to go deeper:
- Melatonin Dosage: How Much Should You Actually Take? — the real dose-response research, and a major hidden problem with product labels
- CBD and Sleep — an honest look at another heavily marketed sleep aid
- Antihistamines (Benadryl/Unisom) for Sleep — the risks behind a common OTC habit
- 5-HTP for Sleep — the precursor step between tryptophan and serotonin
What the Research Shows
Leading sleep medicine guidelines recommend against melatonin for general chronic insomnia in adults. The American Academy of Sleep Medicine’s 2017 clinical practice guideline found only a roughly 9-minute reduction in sleep onset latency at the studied 2 mg dose, based on low-quality evidence, leading to a recommendation against its general use for this purpose.
Melatonin’s core biological role is signaling circadian timing, not direct sedation. As a hormone released in response to darkness, melatonin functions more like a “it’s nighttime” signal than a sleep-inducing sedative, which helps explain why its evidence is stronger for circadian timing problems than general insomnia.
Some guidelines support melatonin more strongly in specific populations. A British Association for Psychopharmacology consensus statement recommends prolonged-release melatonin as first-line treatment specifically for insomnia in adults over 55, a population in which natural melatonin production has already declined.
Regulatory treatment of melatonin varies dramatically by country. It’s sold as an unregulated supplement in the US, while functioning as a prescription-only medication in the UK and EU, a difference that reflects real variation in how strictly different health systems interpret the same underlying evidence.
This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment.
Want a Sleep Strategy Based on What Actually Works for You?
Join the free Sleep Nirvana Club course and community for practical, root-cause-first guidance: Join here
When to Seek Professional Help
- You’ve been using melatonin regularly for general insomnia with limited or no benefit
- You’re not sure whether your sleep issue is more circadian (timing-related) or a general sleep difficulty, which affects whether melatonin is even the right tool
- You’re over 55 and want to understand whether melatonin might be more appropriate for your specific situation
- You’re relying on melatonin instead of addressing an underlying cause of chronic insomnia
- You want guidance on dosing, timing, or product quality before continuing to use it
Frequently Asked Questions
Does melatonin actually work for insomnia?
According to the American Academy of Sleep Medicine’s 2017 clinical practice guideline, the evidence doesn’t support it as an effective treatment for general chronic insomnia in adults, the studied dose produced only a roughly 9-minute reduction in sleep onset time compared to placebo. It’s better supported for circadian timing issues like jet lag or shift work than for general difficulty sleeping.
If melatonin isn’t recommended for insomnia, why do so many people use it?
It has a strong safety profile compared to prescription sedatives, some individuals do respond well to it, and it’s widely available and heavily marketed. Its popularity reflects accessibility and marketing more than it reflects strong evidence for treating general chronic insomnia specifically.
Is melatonin more effective for some people than others?
It appears to be, particularly for circadian rhythm issues (like jet lag or shift work) and in older adults, whose natural melatonin production has declined with age. Some guidelines outside the US specifically recommend prolonged-release melatonin as a first-line option for insomnia in people over 55.
Why is melatonin available over the counter in the US but by prescription elsewhere?
This reflects different regulatory interpretations of similar evidence. In the US, melatonin is sold as an unregulated dietary supplement. In the UK and EU, it’s regulated as a prescription medication specifically indicated for insomnia in adults over 55, a more targeted, evidence-specific use case than general over-the-counter sales suggest.
What is melatonin actually good for, if not general insomnia?
Its clearest, best-supported uses are circadian timing problems, jet lag, shift work adjustment, and delayed sleep phase syndrome, where the goal is shifting when your body wants to sleep rather than simply making you sleepier. It also has more support for use in older adults specifically.
When to Work With a Sleep Consultant
Melatonin is one of the most popular sleep aids in the world, and also one of the most misunderstood. Its real evidence base points to a narrower, more specific set of uses than most people assume. If it hasn’t worked for you, that may say more about fit than failure.
